D100 risk-assignment analysis of plasma metabolites to predict the later development of late aGVHD. We compared plasma samples obtained at D100 from subjects who later developed late aGVHD ≥day 114 (n = 45) with controls (n = 110) to those who did not develop either late aGVHD or cGVHD. The identical identifying metabolic color code and selection criteria as in Figure 1 were used in this figure.